A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT02394028 · COMPLETED
Trial details
- NCT number
- NCT02394028
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-20
- Primary completion
- 2021-09-07
- Enrollment
- 1035
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.